Skip to main content
OpenTrials
Completed

NCT Number: NCT04823234

Lung Ultrasound Signs and Patterns in COVID-19 Pregnant Women

SARS-CoV-2 impact on pregnant women is not well known yet. Some authors demonstrated that lung ultrasound can give similar results if compared to chest computed tomography and better results if compared to chest x-rays without radiations and limited risks for mother and fetus.

The Lung Ultrasound Score (LUS) can be used to asses the entity and monitor the evolution of lung impairment.

Some authors described an artifact, the "light beam", as a typical ultrasound sign in COVID-19 positive patients.

With our study we hypothesize to understand the prevalence of this sign and other ultrasound signs in pregnant COVID-19 positive patients.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Pregnancy Complications COVID-19 Coronaviridae Infections Coronavirus Infections Covid19 Female Urogenital Diseases and Pregnancy Complications Infections Lung Diseases Nidovirales Infections Pneumonia Pneumonia, Viral RNA Virus Infections Respiratory Tract Diseases Respiratory Tract Infections Urogenital Diseases Virus Diseases

Age range

18 year–55 year

Sex eligibility

Female

Study type

Observational

Primary location

Anesthesiology and Intensive Care Clinic - Department of Medicine - ASUIUD

Udine, 33100, Italy

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • All pregnant COVID 19 positive patients admitted at our institution who had lung ultrasound performed

Exclusion criteria

  • are < 18 years old
  • history of rheumatic disease
  • history of spontaneous pneumothorax
  • fibrothorax
  • history of thoracic surgery
  • no consent given

Treatment and study plan

Lung Ultrasound

Diagnostic Test

Lung ultrasound signs in Covid 19 positive pregnant patients

Primary outcomes

  1. Light Beam

    Time frame: 24 hours after admission

    Evaluate the prevalence of the light beam sign

Secondary outcomes

  1. Ultrasound patterns

    Time frame: 24 hours after admission

    Evaluate the prevalence of ultrasound signs and patterns during pregnancy

  2. Lung ultrasound score

    Time frame: 24 hours after admission

    Evaluate if the Lung ultrasound score relates with the clinical presentation of the patient

  3. Illness severity

    Time frame: 24 hours after admission

    Evaluate if the lung ultrasound score relates with the prognosis

  4. Length of stay

    Time frame: 24 hours after admission

    Evaluate if the lung ultrasound score relates with the length of stay

Sponsors and collaborators

Lead sponsor

Azienda Sanitaria-Universitaria Integrata di Udine

Other

Registry information

Official study title

Lung Ultrasound Signs and Patterns in COVID-19 Pregnant Women - "The PINK-CO Protocol"

Acronym: PINK-CO

Important dates

Study start
2021
Primary completion
2021
Study completion
2021
First posted
Mar 30, 2021
Registry last updated
Sep 28, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.